DarioHealth Corp (DRIO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DarioHealth Corp (DRIO) has a cash flow conversion efficiency ratio of -0.100x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.49 Million) by net assets ($55.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of DarioHealth Corp for the company's overall valuation and market capitalisation.
DarioHealth Corp - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how DarioHealth Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
DarioHealth Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DarioHealth Corp ranked by their cash flow conversion efficiency. Explore DRIO cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hyperfine Inc
NASDAQ:HYPR
|
-0.127x |
|
Kingstate Electronics
TWO:3206
|
0.095x |
|
Lixte Biotechnology Holdings Inc
NASDAQ:LIXT
|
-0.200x |
|
South West Pinnacle Exploration Limited
NSE:SOUTHWEST
|
-0.016x |
|
artnet AG Namens-Aktien o.N.
XETRA:ART
|
0.034x |
|
Pinetree Capital Ltd
TO:PNP
|
-0.082x |
|
Akoya Biosciences Inc
NASDAQ:AKYA
|
1.225x |
|
Minda Global Bhd
KLSE:5166
|
0.012x |
Annual Cash Flow Conversion Efficiency for DarioHealth Corp (2012–2025)
The table below shows the annual cash flow conversion efficiency of DarioHealth Corp from 2012 to 2025. View DarioHealth Corp (DRIO) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $67.92 Million | $-25.94 Million | -0.382x | +28.67% |
| 2024-12-31 | $72.02 Million | $-38.56 Million | -0.535x | -2.48% |
| 2023-12-31 | $58.14 Million | $-30.38 Million | -0.522x | +12.64% |
| 2022-12-31 | $80.00 Million | $-47.84 Million | -0.598x | -1.50% |
| 2021-12-31 | $85.55 Million | $-50.41 Million | -0.589x | +6.47% |
| 2020-12-31 | $28.15 Million | $-17.74 Million | -0.630x | +24.30% |
| 2019-12-31 | $18.89 Million | $-15.72 Million | -0.832x | +35.24% |
| 2018-12-31 | $8.93 Million | $-11.47 Million | -1.285x | +52.30% |
| 2017-12-31 | $3.94 Million | $-10.62 Million | -2.694x | -310.34% |
| 2016-12-31 | $-6.54 Million | $-8.38 Million | 1.281x | +115.86% |
| 2015-12-31 | $777.00K | $-6.28 Million | -8.079x | -338.94% |
| 2014-12-31 | $-2.54 Million | $-8.58 Million | 3.381x | -96.16% |
| 2013-12-31 | $-86.38K | $-7.60 Million | 87.979x | +3053.32% |
| 2012-12-31 | $-1.07 Million | $-2.98 Million | 2.790x | -- |
About DarioHealth Corp
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to crea… Read more